Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and feared side effects that occur in pediatric patients undergoing chemotherapy. CINV is an issue that impacts the daily activities, treatment compliance, and overall health care costs for many children. Despite the development and administration of multiple antiemetic medications, CINV affects up to 40% of pediatric patients. Thus, there is an urgent need to develop effective and safe alternative therapies for treating CINV in children (Gupta et al., 2021).